Trial NCT02934503

View at ClinicalTrials.gov 
Org. Study IDs: 16-01031

Last trial update was posted on 2021-11-16

MeSH Interventions

Carboplatin Etoposide Pembrolizumab

MeSH Conditions

Lung Neoplasms Small Cell Lung Carcinoma

Other Conditions

Small Cell Lung Cancer (SCLC)

Stopping Reasons

This study was terminated as the standard of care for small cell lung cancer changed in 2018 to include immunotherapy in the front line setting, making this study no longer clinically relevant.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID